To sum up, we speculate that the mechanism of action of IGU on SLE may be exerted through the hub targets described earlier and the related protein, especially in NF-κB, MAPK, PI3K/AKT, inhibition of abnormal apoptosis, and other pathways. Here, NFKB1 is linked to systemic lupus erythematosus.